comprehensive -WSS

comprehensive

author：comprehensive 2025-09-29 04:12:00 - browse：814

Ionis Pharmaceuticals, a California biotech that has spearheaded the development of RNA-targeting medicines, announced on Tuesday that its drug against familial chylomicronemia syndrome, a rare and serious disease that prevents the body from breaking down fats, succeeded in a late-stage clinical trial.

The Phase 3 trial, dubbed Balance, enrolled 66 adults who were randomly divided into three groups and given a monthly injection of placebo or one of two doses of olezarsen, the company’s experimental drug. Treatment with the higher dose of the therapy significantly lowered triglycerides in the blood of those on the drug for six months compared to participants given placebo, though a lower dose did not have this effect. Participants on the high dose didn’t have any instances of painful inflammation of the pancreas, one of the disease’s most serious symptoms, while there were 11 such episodes among those on placebo.

Researchers reported that the treatment was also generally safe, with fewer adverse events among those on olezarsen than among the placebo group.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Russian and Belarusian players banned from a women's tennis tournament in Prague

hotspot

WSS

Sana to lay off nearly a third of staff, de

China demands US invite Hong Kong leader to economic meeting, adding to strains over crackdown

5 wounded, 2 critically, in Michigan shopping center shooting

Chan Zuckerberg Biohub Chicago to focus on inflammation

Senate panel eyes new effort on drug shortages

Physician executives need more than on

Wikipedia

comprehensive

hotspot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

Medical leaders decry Supreme Court decision on affirmative action

Chemotherapy drug shortage eases slightly but still widespread

Guidelines to prevent youth baseball injuries need more muscle

FDA panel signals lack of confidence in Amgen cancer drug data

Heart attack and stroke risk calculators need revising

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

Tori Bowie and the unacceptable rates of Black maternal death

Stroke deaths set to near 10 million globally by 2050

Wikipedia

5 wounded, 2 critically, in Michigan shopping center shooting

9 mass shootings over the weekend rock US cities, leaving 5 dead, 56 injured

A pollution tax on older cars can be extended to London's suburbs after a British court ruling

Adidas to release second batch of Yeezy sneakers after breakup with Ye

Sana to lay off nearly a third of staff, de

China demands US invite Hong Kong leader to economic meeting, adding to strains over crackdown

hotspot

Wikipedia

knowledge

hotspot